New pill could help shed pounds: obesity drug trial begins

NCT ID NCT07570758

Recruiting now Disease control Sponsor: ERX Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral drug, ERX1000, for weight loss in 80 adults with obesity (BMI 30-50). Participants will take the drug or a placebo daily for 24 weeks. The main goals are to check safety and see how much weight is lost. This is an early-phase trial, so the drug is not yet proven or available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Monroe Biomedical Research
RECRUITING

Louisville, Kentucky, 40213, United States

Contact
Monroe Biomedical Research
RECRUITING

Monroe, North Carolina, 28112, United States

Contact
Monroe Biomedical Research
RECRUITING

North Charleston, South Carolina, 29406, United States

Contact